Skip to content

Vericel VCEL Other Working Capital

Other Working Capital at other companies

Stryker logo
StrykerSYK
$25M-80.8%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$23.5M-23,600%
Enovis logo
EnovisENOV
$14.17M+249%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
$6.59K+104%

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's other working capital?
Vericel (VCEL) reported other working capital of -$21K in Q1 2026.
How has Vericel's other working capital changed year-over-year?
Vericel's other working capital decreased by 425.0% year-over-year, from -$4K to -$21K.
What is the long-term trend for Vericel's other working capital?
Over 3 years (2022 to 2025), Vericel's other working capital has grown at a -16.1% compound annual growth rate (CAGR), from -$22K to -$13K.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.